Antidiabetic effect of an engineered bacterium Lactobacillus plantarum-pMG36e -GLP-1 in monkey model

Glucagon-like peptide-1 (GLP-1) reduces postprandial hyperglycaemia, but its short half-life inhibits clinical application. The aim of the current study was to evaluate the treatment efforts of an engineered strain, Lactobacillus plantarum-pMG36e-GLP-1 (L. plantarum-pMG36e-GLP-1), that continuously...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jie, Zhang, Hongfei, Lu, Jiachen, Ma, ChaoLin, Chen, Tingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455315/
https://www.ncbi.nlm.nih.gov/pubmed/34584995
http://dx.doi.org/10.1016/j.synbio.2021.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455315/
https://www.ncbi.nlm.nih.gov/pubmed/34584995
http://dx.doi.org/10.1016/j.synbio.2021.09.009

Ejemplares similares